Latest Breaking News On - Australia new zealand clinical trial registry - Page 1 : comparemela.com

"In-person versus electronic screening for social risks among carers of" by Lisa Gaye Smithers, Catherine MacPhail et al.

Recce Pharmaceuticals Announces Safety Committee Approves Next Dose of RECCE® 327 at 3,000mg in Phase I/II UTI/Urosepsis Rapid Infusion Clinical Trial

Recce Pharmaceuticals Doses Patients in Phase I/II Clinical Trial of RECCE® 327 for Diabetic Foot Infections

Recce Pharmaceuticals Ltd tackling antibiotic-resistant 'superbugs' with synthetic anti-infectives

Superbugs that are resistant to antibiotics are causing an urgent global health crisis, but Recce Pharmaceuticals believes it has the solution.

NZ clinical trial boom post-Covid slowly but surely emerging

Despite slow Covid recovery globally, enquiries for future NZ trials hit 10-year high. The Covid clinical trial boom that seemed inevitable for a healthcare system virtually untouched by a global pandemic has been slow to materialise, but industry stalwarts say it’s still on the horizon.  The Australia New Zealand Clinical Trial Registry found in the first four months of 2021 there was, in fact, a marked decrease in the typical number of clinical trials.  During the January to April period in 2018, there were 145 trials under way; in 2019, there were 124; and in 2020, 111. By comparison, in the past four months, only 79 clinical trials are under way in New Zealand - a 35%